Cancer Res (2024) 84 (17_Supplement_2): A030.
ARV-471 is a selective, orally bioavailable PROteolysis-TArgeting Chimera (PROTAC®) small molecule that induces wild-type and mutant estrogen receptor (ER) alpha degradation via the ...
For authors of Research Articles that have been declined for publication at an AACR journal, the AACR offers the corresponding author the option to easily transfer manuscript files and supporting ...
Crossmark is a multi-publisher initiative from Crossref to provide a standard way for readers to locate the current version of a piece of content. By applying the Crossmark logo, the American ...
The Reproducibility Project: Cancer Biology has clearly highlighted the need for published articles to contain more detail of exactly how each study was conducted. This page describes AACR journal ...
Abstract. CD8+ T-cells are responsible for detection and killing of hosT-cells expressing non-self proteins. Upon antigen persistence, as in cancer or chronic viral infection, antigen-specific CD8+ ...
These services available to all authors submitting to AACR journals are intended to assist with manuscript preparation, facilitate rapid publication in an appropriate AACR journal, and improve the ...
University of Minnesota, Minneapolis, MN.
Infrequently mutated genes comprise most of the mutational burden in breast tumors but are poorly understood. In vivo CRISPR screening identified functional tumor suppressors that converged on ...
Cancer Res (2023) 83 (8_Supplement): LB031.
In 1978, a Cancer Research article by Dougherty and colleagues reported the first large-scale clinical trial of photodynamic therapy (PDT) for treatment of 113 cutaneous or subcutaneous lesions ...
1Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, New York.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results